Morgan Stanley Reiterates a Buy Rating on Dyne Therapeutics (DYN), Keeps the PT
Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the Best Small-Cap Growth Stocks to Buy Right Now. On August 4, Michael Ulz of Morgan Stanley reiterated a Buy rating on Dyne Therapeutics, Inc.